|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases response to substance multiple interactions |
ISO EXP |
ABCB1 protein results in decreased susceptibility to Dactinomycin Dactinomycin inhibits the reaction [Estradiol results in increased expression of ABCB1 mRNA]; Dactinomycin inhibits the reaction [Estradiol results in increased expression of ABCB1 protein]; Dactinomycin inhibits the reaction [Progesterone results in increased expression of ABCB1 mRNA]; Dactinomycin inhibits the reaction [Progesterone results in increased expression of ABCB1 protein]; Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of ABCB1 mRNA] Dactinomycin inhibits the reaction [[Particulate Matter results in increased expression of and results in increased activity of ABCB1 protein] which results in increased uptake of (N-5-(4-nitrobenzofurazan-7-yl)lysyl(8))cyclosporine]; Dactinomycin inhibits the reaction [[Vehicle Emissions results in increased expression of and results in increased activity of ABCB1 protein] which results in increased uptake of (N-5-(4-nitrobenzofurazan-7-yl)lysyl(8))cyclosporine]; Dactinomycin inhibits the reaction [coptisine results in increased expression of ABCB1A mRNA]; Dactinomycin inhibits the reaction [Particulate Matter results in increased expression of and results in increased activity of ABCB1 protein]; Dactinomycin inhibits the reaction [tetrabromobisphenol A results in increased expression of and results in increased activity of ABCB1A protein]; Dactinomycin inhibits the reaction [Vehicle Emissions results in increased expression of and results in increased activity of ABCB1 protein] |
CTD |
PMID:1967174 PMID:11455017 PMID:15725475 PMID:18474546 PMID:19813763 PMID:20410605 PMID:30830211 More...
|
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [coptisine results in increased expression of ABCB1B mRNA] |
CTD |
PMID:20410605 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
decreases response to substance |
ISO EXP |
ABCC1 protein results in decreased susceptibility to Dactinomycin |
CTD |
PMID:11455017 PMID:12067707 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
decreases response to substance multiple interactions |
EXP ISO |
ABCC2 protein results in decreased susceptibility to Dactinomycin Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of ABCC2 mRNA] Dactinomycin inhibits the reaction [Bucladesine results in increased expression of ABCC2 mRNA] |
CTD |
PMID:11408547 PMID:11455017 PMID:26049102 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Daunorubicin results in increased expression of ABCG2 mRNA]; Dactinomycin inhibits the reaction [Doxorubicin results in increased expression of ABCG2 mRNA]; Dactinomycin inhibits the reaction [Mitoxantrone results in increased expression of ABCG2 mRNA]; Dactinomycin inhibits the reaction [SHH protein alternative form results in increased expression of ABCG2 protein]; Dactinomycin inhibits the reaction [Sulfasalazine results in increased expression of ABCG2 mRNA] |
CTD |
PMID:20019844 PMID:21625222 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Abhd3 |
abhydrolase domain containing 3, phospholipase |
increases expression |
ISO |
Dactinomycin results in increased expression of ABHD3 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr18:1,723,203...1,778,488
Ensembl chr18:1,720,718...1,803,428
|
|
G |
Ace |
angiotensin I converting enzyme |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Aldosterone results in increased activity of ACE protein]; Dactinomycin inhibits the reaction [Aldosterone results in increased expression of ACE mRNA] |
CTD |
PMID:15932931 |
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid results in increased expression of ACSL6 mRNA] |
CTD |
PMID:10585473 |
|
NCBI chr10:38,439,914...38,501,182
Ensembl chr10:38,440,080...38,498,757
|
|
G |
Adam9 |
ADAM metallopeptidase domain 9 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Hydrogen Peroxide results in increased expression of ADAM9 protein] |
CTD |
PMID:17018608 |
|
NCBI chr16:67,022,538...67,101,647
Ensembl chr16:67,022,655...67,100,917
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Cycloheximide results in increased expression of ADRB2 protein]; Dactinomycin inhibits the reaction [EDN1 protein results in increased expression of ADRB2 mRNA]; Dactinomycin inhibits the reaction [Formoterol Fumarate affects the expression of ADRB2 mRNA] |
CTD |
PMID:22483689 PMID:24705868 |
|
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Agrp |
agouti related neuropeptide |
decreases expression multiple interactions |
ISO |
Dactinomycin results in decreased expression of AGRP mRNA Dactinomycin inhibits the reaction [bisphenol A results in increased expression of AGRP mRNA] |
CTD |
PMID:32575098 |
|
NCBI chr19:33,447,992...33,481,602
Ensembl chr19:33,447,992...33,449,584
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
ISO EXP |
Dactinomycin inhibits the reaction [AGT protein results in increased expression of CCL2 mRNA]; Dactinomycin inhibits the reaction [Amiodarone results in increased expression of AGT mRNA] Dactinomycin inhibits the reaction [AGT protein results in increased expression of CACNA1G mRNA]; Dactinomycin inhibits the reaction [AGT protein results in increased expression of CACNA1H mRNA]; Dactinomycin promotes the reaction [Spironolactone inhibits the reaction [AGT protein results in increased expression of CTF1 mRNA]]; Dactinomycin promotes the reaction [Valsartan inhibits the reaction [AGT protein results in increased expression of CTF1 mRNA]] |
CTD |
PMID:16705055 PMID:17214612 PMID:19292980 PMID:23288202 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [TGFB1 protein results in decreased expression of AHR mRNA] ARNT protein promotes the reaction [Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased degradation of AHR protein]]; Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of AHR protein]; Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased degradation of AHR protein] |
CTD |
PMID:9145908 PMID:16226227 PMID:25637755 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aicda |
activation-induced cytidine deaminase |
multiple interactions |
ISO |
[Dactinomycin co-treated with Alpha-Amanitin] inhibits the reaction [Estradiol results in increased expression of AICDA mRNA] |
CTD |
PMID:19139166 |
|
NCBI chr 4:155,774,132...155,783,972
Ensembl chr 4:155,774,132...155,783,972
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
multiple interactions |
ISO |
[Dactinomycin co-treated with TNFSF10 protein] results in increased expression of AIFM1 protein |
CTD |
PMID:17707539 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases stability |
ISO |
PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of AKT1 protein] PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of AKT1 protein]; YTHDF1 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]; YTHDF1 protein affects the reaction [YTHDF2 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]]; YTHDF2 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]; YTHDF2 protein affects the reaction [YTHDF1 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]] |
CTD |
PMID:14640974 PMID:37061066 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alpi |
alkaline phosphatase, intestinal |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Fish Oils results in increased activity of ALPI protein] |
CTD |
PMID:15599000 |
|
NCBI chr 9:87,773,411...87,776,877
Ensembl chr 9:87,773,411...87,776,877
|
|
G |
Alx3 |
ALX homeobox 3 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Folic Acid results in increased expression of ALX3 mRNA] |
CTD |
PMID:20534379 |
|
NCBI chr 2:195,231,197...195,241,609
Ensembl chr 2:195,231,197...195,241,609
|
|
G |
Aoc1 |
amine oxidase, copper containing 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Epinephrine results in increased activity of AOC1 protein]; Dactinomycin inhibits the reaction [Isoproterenol results in increased activity of AOC1 protein]; Dactinomycin inhibits the reaction [Terbutaline results in increased activity of AOC1 protein] |
CTD |
PMID:2860926 PMID:6218830 |
|
NCBI chr 4:77,812,260...77,831,846
Ensembl chr 4:77,812,260...77,831,840
|
|
G |
Aqp1 |
aquaporin 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [cobaltous chloride results in increased expression of AQP1 mRNA] |
CTD |
PMID:22415096 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Arhgdib |
Rho GDP dissociation inhibitor beta |
increases expression |
ISO |
Dactinomycin results in increased expression of ARHGDIB mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions |
ISO |
ARNT protein promotes the reaction [Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased degradation of AHR protein]] |
CTD |
PMID:16226227 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Atf4 |
activating transcription factor 4 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Bortezomib results in increased expression of ATF4 mRNA]; Dactinomycin inhibits the reaction [Bortezomib results in increased expression of ATF4 protein]; Dactinomycin inhibits the reaction [Fenretinide results in increased expression of ATF4 mRNA]; Dactinomycin inhibits the reaction [Fenretinide results in increased expression of ATF4 protein]; Dactinomycin inhibits the reaction [Thapsigargin results in increased expression of ATF4 mRNA]; Dactinomycin inhibits the reaction [Thapsigargin results in increased expression of ATF4 protein] |
CTD |
PMID:20022965 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atg7 |
autophagy related 7 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Ethanol results in increased expression of ATG7 protein] |
CTD |
PMID:24095927 |
|
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
|
|
G |
Atm |
ATM serine/threonine kinase |
multiple interactions |
ISO |
Dactinomycin results in decreased expression of and results in increased phosphorylation of ATM protein |
CTD |
PMID:31226288 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Avp |
arginine vasopressin |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [[Phenylephrine co-treated with Adenosine Triphosphate] results in increased secretion of AVP protein] |
CTD |
PMID:11102496 |
|
NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425
|
|
G |
Axl |
Axl receptor tyrosine kinase |
increases expression |
ISO |
Dactinomycin results in increased expression of AXL mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265
|
|
G |
Bag3 |
BAG cochaperone 3 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Lipopolysaccharides results in increased expression of BAG3 mRNA] |
CTD |
PMID:22020323 |
|
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
multiple interactions |
EXP ISO |
Dactinomycin inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of BAK1 mRNA] Dactinomycin promotes the reaction [BAK1 protein binds to BAK1 protein] |
CTD |
PMID:21281706 PMID:26670606 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO EXP |
Dactinomycin results in increased expression of BAX mRNA; Dactinomycin results in increased expression of BAX protein Morphine inhibits the reaction [Dactinomycin results in increased expression of BAX protein]; Naloxone inhibits the reaction [Morphine inhibits the reaction [Dactinomycin results in increased expression of BAX protein]] Dactinomycin inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of BAX mRNA] Dactinomycin promotes the reaction [BAX protein binds to BAX protein] |
CTD |
PMID:10760829 PMID:12927789 PMID:21281706 PMID:21527772 PMID:26670606 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
increases expression |
ISO |
Dactinomycin results in increased expression of BBC3 mRNA; Dactinomycin results in increased expression of BBC3 protein |
CTD |
PMID:17581298 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
BCL2 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; Dactinomycin inhibits the reaction [Arsenic Trioxide results in increased expression of BCL2 protein]; Dactinomycin inhibits the reaction [IL1B results in increased expression of BCL2 protein]; Dactinomycin inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]; Dactinomycin inhibits the reaction [TNF results in increased expression of BCL2 protein]; Morphine inhibits the reaction [Dactinomycin results in decreased expression of BCL2 protein]; Naloxone inhibits the reaction [Morphine inhibits the reaction [Dactinomycin results in decreased expression of BCL2 protein]] Dactinomycin results in decreased expression of BCL2 mRNA; Dactinomycin results in decreased expression of BCL2 protein |
CTD |
PMID:11726273 PMID:11880364 PMID:12927789 PMID:16492401 PMID:17581298 PMID:34303041 More...
|
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
multiple interactions |
ISO |
BCL2A1 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] |
CTD |
PMID:11880364 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression increases expression multiple interactions |
ISO |
Dactinomycin results in decreased expression of BCL2L1 protein Dactinomycin results in increased expression of BCL2L1 protein; Dactinomycin results in increased expression of BCL2L1 protein alternative form Dexamethasone inhibits the reaction [Dactinomycin results in increased expression of BCL2L1 protein] |
CTD |
PMID:9326359 PMID:12430140 PMID:15592511 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of BCL2L11 mRNA] |
CTD |
PMID:16166651 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions decreases expression |
EXP |
Dactinomycin inhibits the reaction [9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2 analog results in increased expression of BDNF mRNA]; Dactinomycin inhibits the reaction [NEPP11 compound results in increased expression of BDNF mRNA] Dactinomycin results in decreased expression of BDNF mRNA |
CTD |
PMID:22982731 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Ethanol results in increased expression of BECN1 protein] |
CTD |
PMID:24095927 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bid |
BH3 interacting domain death agonist |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [vorinostat results in increased cleavage of BID protein] Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of BID mRNA] |
CTD |
PMID:11535817 PMID:16166651 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
multiple interactions |
ISO |
BIRC3 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] |
CTD |
PMID:11880364 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
multiple interactions |
ISO |
[Dactinomycin co-treated with TNF protein] results in increased expression of BNIP3 mRNA; Dactinomycin inhibits the reaction [Ethanol results in increased expression of BNIP3 protein]; Dactinomycin inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] |
CTD |
PMID:11592958 PMID:19442826 PMID:24095927 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Bsdc1 |
BSD domain containing 1 |
increases expression |
ISO |
Dactinomycin results in increased expression of BSDC1 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 5:141,798,918...141,827,091
Ensembl chr 5:141,798,981...141,827,092
|
|
G |
Btrc |
beta-transducin repeat containing E3 ubiquitin protein ligase |
multiple interactions |
ISO |
Dactinomycin promotes the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of BTRC mRNA]; Dactinomycin promotes the reaction [[WEHI-539 co-treated with venetoclax] results in decreased expression of BTRC mRNA] |
CTD |
PMID:35561756 |
|
NCBI chr 1:244,210,299...244,380,126
Ensembl chr 1:244,210,314...244,376,721
|
|
G |
C1qbp |
complement C1q binding protein |
decreases response to substance |
ISO |
C1QBP protein results in decreased susceptibility to Dactinomycin |
CTD |
PMID:25354864 |
|
NCBI chr10:55,699,954...55,704,605
Ensembl chr10:55,699,954...55,704,649
|
|
G |
Cacna1g |
calcium voltage-gated channel subunit alpha1 G |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [AGT protein results in increased expression of CACNA1G mRNA] |
CTD |
PMID:19292980 |
|
NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752
|
|
G |
Cacna1h |
calcium voltage-gated channel subunit alpha1 H |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [AGT protein results in increased expression of CACNA1H mRNA] |
CTD |
PMID:19292980 |
|
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
|
|
G |
Casp2 |
caspase 2 |
increases cleavage |
ISO |
Dactinomycin results in increased cleavage of CASP2 protein |
CTD |
PMID:10663630 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
multiple interactions decreases expression increases activity |
ISO EXP |
[TNF co-treated with Dactinomycin] results in increased activity of CASP3 protein; [TNF protein co-treated with Dactinomycin] results in increased activity of CASP3 protein; Dactinomycin inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Dactinomycin inhibits the reaction [Biological Products results in increased expression of CASP3 mRNA]; Dactinomycin promotes the reaction [TNF results in increased activity of CASP3 protein] Dactinomycin results in decreased expression of CASP3 mRNA Dactinomycin results in increased activity of CASP3 protein [Dactinomycin co-treated with TNF protein] results in increased activity of CASP3 protein Dactinomycin results in increased cleavage of and results in increased activity of CASP3 protein |
CTD |
PMID:10663630 PMID:16001973 PMID:16492401 PMID:21496118 PMID:22654482 PMID:23300732 PMID:26670606 PMID:34303041 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
multiple interactions decreases expression |
ISO |
[Dactinomycin co-treated with TNFSF10 protein] results in increased activity of CASP7 protein; [TNF co-treated with Dactinomycin] results in increased activity of CASP7 protein; [TNF protein co-treated with Dactinomycin] results in increased activity of CASP7 protein; Dactinomycin promotes the reaction [TNF results in increased activity of CASP7 protein] Dactinomycin results in decreased expression of CASP7 mRNA |
CTD |
PMID:16001973 PMID:16492401 PMID:17707539 PMID:21496118 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
decreases expression |
ISO |
Dactinomycin results in decreased expression of CASP8 mRNA |
CTD |
PMID:16001973 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases cleavage |
ISO |
[Dactinomycin co-treated with TNFSF10 protein] results in increased activity of CASP9 protein Dactinomycin results in increased cleavage of CASP9 protein |
CTD |
PMID:17707539 PMID:26670606 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cav1 |
caveolin 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA] |
CTD |
PMID:15314095 |
|
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [TNF protein results in increased expression of CCL11 mRNA] |
CTD |
PMID:15531761 |
|
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [AGT protein results in increased expression of CCL2 mRNA]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] |
CTD |
PMID:15531761 PMID:16705055 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccn4 |
cellular communication network factor 4 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CCN4 mRNA] |
CTD |
PMID:19238344 |
|
NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248
|
|
G |
Ccna2 |
cyclin A2 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Homocysteine results in increased expression of CCNA2 mRNA] |
CTD |
PMID:8550827 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnd1 |
cyclin D1 |
decreases stability |
ISO |
Dactinomycin results in decreased stability of CCND1 mRNA |
CTD |
PMID:15610522 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd1d1 |
CD1d1 molecule |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Tretinoin results in increased expression of CD1D mRNA] |
CTD |
PMID:17392484 |
|
NCBI chr 2:172,423,582...172,427,089
Ensembl chr 2:172,423,582...172,427,089
|
|
G |
Cd28 |
Cd28 molecule |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD28 protein] |
CTD |
PMID:11465111 |
|
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions decreases expression |
ISO |
2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone inhibits the reaction [Dactinomycin results in increased expression of and affects the localization of CDKN1A protein]; Dactinomycin results in increased expression of and affects the localization of CDKN1A protein Dactinomycin results in decreased expression of CDKN1A protein |
CTD |
PMID:12807743 PMID:14601052 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
ISO |
CDKN1B protein affects the reaction [Dactinomycin results in increased degradation of PTGS2 mRNA] |
CTD |
PMID:23639288 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
decreases expression |
ISO |
Dactinomycin results in decreased expression of CEBPB mRNA |
CTD |
PMID:16001973 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cel |
carboxyl ester lipase |
increases expression |
ISO |
Dactinomycin results in increased expression of CEL mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 3:11,883,532...11,891,035
Ensembl chr 3:11,883,532...11,891,035
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
decreases expression |
ISO |
Dactinomycin results in decreased expression of CFLAR protein |
CTD |
PMID:11234897 PMID:14601052 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Ckb |
creatine kinase B |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Estradiol results in increased expression of CKB protein]; Dactinomycin inhibits the reaction [Methoxychlor results in increased expression of CKB protein] |
CTD |
PMID:7839363 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Clmn |
calmin |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Tretinoin results in increased expression of CLMN mRNA] |
CTD |
PMID:16688769 |
|
NCBI chr 6:123,707,710...123,807,283
Ensembl chr 6:123,713,507...123,807,272
|
|
G |
Cnmd |
chondromodulin |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [hydroquinone results in increased expression of CNMD protein] |
CTD |
PMID:19525446 |
|
NCBI chr15:55,041,548...55,066,297
Ensembl chr15:55,041,561...55,066,297
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Gemcitabine results in increased expression of CNR1 mRNA] |
CTD |
PMID:21525939 |
|
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Cnr2 |
cannabinoid receptor 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Gemcitabine results in increased expression of CNR2 mRNA] |
CTD |
PMID:21525939 |
|
NCBI chr 5:148,125,222...148,151,548
Ensembl chr 5:148,125,604...148,151,548
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions decreases expression |
ISO |
Dactinomycin inhibits the reaction [TGFB2 protein results in increased expression of COL1A1 mRNA] Dactinomycin results in decreased expression of COL1A1 mRNA |
CTD |
PMID:11216681 PMID:18253093 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [LEP protein results in increased expression of COL1A2 mRNA] |
CTD |
PMID:12704794 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Crabp2 |
cellular retinoic acid binding protein 2 |
increases expression |
ISO |
Dactinomycin results in increased expression of CRABP2 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379
|
|
G |
Cs |
citrate synthase |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Hydrocortisone results in decreased activity of CS protein] |
CTD |
PMID:6476976 |
|
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Reactive Oxygen Species results in increased expression of CSF2 protein] Dactinomycin inhibits the reaction [IL1B results in increased secretion of CSF2 protein]; Dactinomycin inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein]; Dactinomycin inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] |
CTD |
PMID:9606035 PMID:10645887 PMID:11752025 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Ctf1 |
cardiotrophin 1 |
multiple interactions |
EXP |
Dactinomycin promotes the reaction [Spironolactone inhibits the reaction [AGT protein results in increased expression of CTF1 mRNA]]; Dactinomycin promotes the reaction [Valsartan inhibits the reaction [AGT protein results in increased expression of CTF1 mRNA]] |
CTD |
PMID:23288202 |
|
NCBI chr 1:182,328,035...182,336,346
Ensembl chr 1:182,328,090...182,333,335
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of CYCS mRNA] |
CTD |
PMID:21281706 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cygb |
cytoglobin |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole results in increased expression of CYGB mRNA] |
CTD |
PMID:25781201 |
|
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions decreases expression |
ISO |
Dactinomycin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [chromium trioxide results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Copper results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Lead results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Mercury results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [SB 203580 results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [tetrandrine results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [tetrandrine results in increased expression of CYP1A1 protein]; Dactinomycin promotes the reaction [benz(a)anthracene results in increased expression of CYP1A1 mRNA]; Dactinomycin promotes the reaction [Cycloheximide results in increased expression of CYP1A1 mRNA] Dactinomycin inhibits the reaction [afimoxifene results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [cryptotanshinone results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [dihydrotanshinone I results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [harman results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Itraconazole results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Ketoconazole results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [NSC 674495 results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Quercetin results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Skatole results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Sunitinib results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [T-2 Toxin results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [tanshinone results in increased expression of CYP1A1 mRNA] Dactinomycin results in decreased expression of CYP1A1 mRNA |
CTD |
PMID:1934297 PMID:10359656 PMID:11577022 PMID:11752201 PMID:16093525 PMID:17283379 PMID:17606337 PMID:19901195 PMID:20187624 PMID:20732341 PMID:21262253 PMID:21732638 PMID:23288144 PMID:26318284 PMID:26640276 PMID:31470059 More...
|
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [cryptotanshinone results in increased expression of CYP1A2 mRNA]; Dactinomycin inhibits the reaction [dihydrotanshinone I results in increased expression of CYP1A2 mRNA]; Dactinomycin inhibits the reaction [tanshinone results in increased expression of CYP1A2 mRNA] |
CTD |
PMID:21262253 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions decreases expression |
ISO EXP |
Dactinomycin inhibits the reaction [NSC 674495 results in increased expression of CYP1B1 mRNA] Dactinomycin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA] Dactinomycin results in decreased expression of CYP1B1 mRNA Dactinomycin inhibits the reaction [Vehicle Emissions results in increased expression of CYP1B1 protein] |
CTD |
PMID:11577022 PMID:11752201 PMID:21867498 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Phenobarbital results in increased expression of CYP2B10 mRNA] |
CTD |
PMID:9007836 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Skatole results in increased expression of CYP2F1 mRNA] |
CTD |
PMID:20187624 |
|
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Cyp2s1 |
cytochrome P450, family 2, subfamily s, polypeptide 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP2S1 mRNA] |
CTD |
PMID:17277313 |
|
NCBI chr 1:81,309,948...81,325,303
Ensembl chr 1:81,310,451...81,325,303
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
EXP ISO |
Dactinomycin inhibits the reaction [Methylcholanthrene results in increased expression of CYP3A2 mRNA]; Dactinomycin inhibits the reaction [Phenobarbital results in increased expression of CYP3A2 mRNA]; Dactinomycin inhibits the reaction [pyridine results in increased expression of CYP3A2 mRNA] Dactinomycin inhibits the reaction [o,p'-DDT results in increased expression of CYP3A4 mRNA]; Dactinomycin inhibits the reaction [U 0126 results in increased expression of CYP3A4 mRNA] |
CTD |
PMID:11181506 PMID:15795092 PMID:24819614 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Phenobarbital results in increased expression of CYP3A23-3A1 mRNA]; Dactinomycin inhibits the reaction [pyridine results in increased expression of CYP3A23-3A1 mRNA] |
CTD |
PMID:11181506 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [U 0126 results in increased expression of CYP3A5 mRNA] |
CTD |
PMID:24819614 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Ddah2 |
DDAH family member 2, ADMA-independent |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Nebivolol results in increased expression of DDAH2 mRNA] |
CTD |
PMID:17977009 |
|
NCBI chr20:3,761,460...3,764,718
Ensembl chr20:3,761,465...3,764,511
|
|
G |
Dio3 |
iodothyronine deiodinase 3 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Hydrogen Peroxide results in increased activity of DIO3 protein] |
CTD |
PMID:18420745 |
|
NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660
|
|
G |
Dpysl4 |
dihydropyrimidinase-like 4 |
increases expression |
ISO |
Dactinomycin results in increased expression of DPYSL4 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 1:193,883,039...193,898,916
Ensembl chr 1:193,883,106...193,898,914
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [EDN1 protein results in increased expression of ADRB2 mRNA] |
CTD |
PMID:22483689 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Ednra |
endothelin receptor type A |
multiple interactions |
EXP |
[Dimethyl Sulfoxide co-treated with Dactinomycin] results in decreased expression of EDNRA mRNA; [Dimethyl Sulfoxide co-treated with Dactinomycin] results in decreased expression of EDNRA protein; Dactinomycin inhibits the reaction [Particulate Matter results in increased expression of EDNRA mRNA]; Dactinomycin inhibits the reaction [Particulate Matter results in increased expression of EDNRA protein] |
CTD |
PMID:20561571 |
|
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
|
|
G |
Ednrb |
endothelin receptor type B |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Cyclosporine results in increased expression of EDNRB mRNA]; Dactinomycin inhibits the reaction [Dimethyl Sulfoxide results in increased expression of EDNRB mRNA]; Dactinomycin inhibits the reaction [Dimethyl Sulfoxide results in increased expression of EDNRB protein]; Dactinomycin inhibits the reaction [Particulate Matter results in increased expression of EDNRB mRNA]; Dactinomycin inhibits the reaction [Particulate Matter results in increased expression of EDNRB protein]; Dactinomycin inhibits the reaction [Smoke analog results in increased expression of EDNRB protein]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of EDNRB mRNA] |
CTD |
PMID:20561571 PMID:20716444 PMID:22207076 PMID:25772258 |
|
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
|
|
G |
Efnb2 |
ephrin B2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Tretinoin results in increased expression of EFNB2 mRNA] |
CTD |
PMID:16688769 |
|
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [[EGF protein co-treated with Estradiol] results in increased expression of FOS mRNA] |
CTD |
PMID:12632255 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Estradiol results in increased expression of EGFR protein]; Dactinomycin inhibits the reaction [Methoxychlor results in increased expression of EGFR protein] |
CTD |
PMID:8888411 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Estradiol results in increased expression of EGR1 mRNA] |
CTD |
PMID:1717835 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Elovl3 |
ELOVL fatty acid elongase 3 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Norepinephrine results in increased expression of ELOVL3 mRNA]; Dactinomycin inhibits the reaction [rosiglitazone results in increased expression of ELOVL3 mRNA] |
CTD |
PMID:17726147 |
|
NCBI chr 1:244,997,287...245,001,115
Ensembl chr 1:244,997,287...245,001,115
|
|
G |
Emp1 |
epithelial membrane protein 1 |
increases expression |
ISO |
Dactinomycin results in increased expression of EMP1 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904
|
|
G |
Emp3 |
epithelial membrane protein 3 |
increases expression |
ISO |
Dactinomycin results in increased expression of EMP3 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
increases stability |
EXP |
Dactinomycin results in increased stability of EPAS1 protein |
CTD |
PMID:23545307 |
|
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
F3 |
coagulation factor III, tissue factor |
decreases expression multiple interactions |
ISO |
Dactinomycin results in decreased expression of F3 mRNA Dactinomycin inhibits the reaction [indoleacetic acid results in increased expression of F3 mRNA] |
CTD |
PMID:30324315 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Fadd |
Fas associated via death domain |
decreases expression |
ISO |
Dactinomycin results in decreased expression of FADD mRNA |
CTD |
PMID:16001973 |
|
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fads3 |
fatty acid desaturase 3 |
increases expression |
ISO |
Dactinomycin results in increased expression of FADS3 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 1:206,685,667...206,702,538
Ensembl chr 1:206,685,894...206,704,769
|
|
G |
Fbl |
fibrillarin |
affects localization |
ISO |
Dactinomycin analog affects the localization of FBL protein |
CTD |
PMID:10942594 |
|
NCBI chr 1:83,469,832...83,478,932
Ensembl chr 1:83,469,832...83,478,932
|
|
G |
Fcar |
Fc alpha receptor |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Benzo(a)pyrene results in increased expression of FCAR mRNA] |
CTD |
PMID:21911031 |
|
NCBI chr 1:69,626,458...69,660,558
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
multiple interactions decreases expression |
ISO EXP |
Dactinomycin inhibits the reaction [Sodium Chloride results in increased expression of FGF2 mRNA] Dactinomycin results in decreased expression of FGF2 mRNA Dactinomycin inhibits the reaction [FGF2 protein results in increased expression of SNCA protein] |
CTD |
PMID:12562524 PMID:26800359 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Triiodothyronine results in increased expression of FGFR1 mRNA] |
CTD |
PMID:12805413 |
|
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Fhl1 |
four and a half LIM domains 1 |
multiple interactions |
EXP |
Dactinomycin promotes the reaction [25-hydroxycholesterol results in increased expression of FHL1 mRNA] |
CTD |
PMID:17161435 |
|
NCBI chr X:134,555,399...134,614,930
Ensembl chr X:134,555,479...134,614,928
|
|
G |
Flnc |
filamin C |
increases expression |
ISO |
Dactinomycin results in increased expression of FLNC mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 4:58,034,088...58,061,882
Ensembl chr 4:58,034,189...58,061,844
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [TGFB2 protein results in increased expression of FN1 mRNA] |
CTD |
PMID:18253093 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions decreases expression |
ISO EXP |
Dactinomycin inhibits the reaction [beryllium sulfate results in increased expression of FOS mRNA]; Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of FOS mRNA] Dactinomycin inhibits the reaction [[Cycloheximide co-treated with Cadmium] results in increased expression of FOS mRNA]; Dactinomycin inhibits the reaction [[EGF protein co-treated with Estradiol] results in increased expression of FOS mRNA]; Dactinomycin inhibits the reaction [Fructose results in increased expression of FOS mRNA]; Dactinomycin inhibits the reaction [Glucose results in increased expression of FOS mRNA]; Dactinomycin inhibits the reaction [IL1A protein results in increased expression of FOS mRNA] Dactinomycin results in decreased expression of FOS mRNA Dactinomycin inhibits the reaction [Hemin results in increased expression of FOS mRNA] |
CTD |
PMID:1696944 PMID:7564102 PMID:10381381 PMID:11123204 PMID:11353138 PMID:11568973 PMID:12632255 More...
|
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
multiple interactions decreases expression |
ISO |
Dactinomycin inhibits the reaction [Particulate Matter results in increased expression of FOSL1 mRNA]; Dactinomycin inhibits the reaction [Vehicle Emissions results in increased expression of FOSL1 mRNA] Dactinomycin results in decreased expression of FOSL1 mRNA |
CTD |
PMID:14565943 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Isoproterenol results in increased activity of G6PD protein] |
CTD |
PMID:1978808 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
multiple interactions increases expression |
ISO |
Dactinomycin inhibits the reaction [arsenite results in increased expression of GADD45A mRNA] Dactinomycin results in increased expression of GADD45A mRNA |
CTD |
PMID:17616671 PMID:21527772 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Galm |
galactose mutarotase |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Tretinoin results in increased expression of GALM mRNA] |
CTD |
PMID:18052213 |
|
NCBI chr 6:14,837,540...14,889,484
Ensembl chr 6:14,837,548...14,889,310
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
increases expression |
ISO |
Dactinomycin results in increased expression of GAPDH mRNA |
CTD |
PMID:16001973 |
|
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gas6 |
growth arrest specific 6 |
multiple interactions increases degradation |
ISO |
Phosphates promotes the reaction [Dactinomycin results in increased degradation of GAS6 mRNA] |
CTD |
PMID:20048160 |
|
NCBI chr16:76,045,430...76,075,904
Ensembl chr16:76,045,426...76,075,904
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions |
ISO EXP |
Dactinomycin inhibits the reaction [Vitamin K 3 results in increased expression of GCLC mRNA] Dactinomycin inhibits the reaction [notoginsenoside R1 results in increased expression of GCLC protein] |
CTD |
PMID:11972604 PMID:24437944 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gdf15 |
growth differentiation factor 15 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [resveratrol results in increased expression of GDF15 mRNA] |
CTD |
PMID:17257620 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
multiple interactions decreases expression |
EXP |
Dactinomycin inhibits the reaction [9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2 analog results in increased expression of GDNF mRNA]; Dactinomycin inhibits the reaction [NEPP11 compound results in increased expression of GDNF mRNA] Dactinomycin results in decreased expression of GDNF mRNA |
CTD |
PMID:22982731 |
|
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
increases secretion multiple interactions |
EXP |
Dactinomycin results in increased secretion of GFER protein Dactinomycin promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of GFER protein]; lipopolysaccharide, Escherichia coli O111 B4 promotes the reaction [Dactinomycin results in increased secretion of GFER protein] |
CTD |
PMID:23073658 |
|
NCBI chr10:13,718,489...13,721,782
Ensembl chr10:13,718,489...13,720,869
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions |
EXP |
Dactinomycin promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 mRNA] |
CTD |
PMID:36863560 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gpr137b |
G protein-coupled receptor 137B |
increases expression |
ISO |
Dactinomycin results in increased expression of GPR137B mRNA |
CTD |
PMID:21527772 |
|
NCBI chr17:86,003,635...86,041,841
Ensembl chr17:85,966,921...86,041,835
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [[Corn Oil co-treated with (5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid] results in increased activity of GPT protein] |
CTD |
PMID:29479035 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Grm5 |
glutamate metabotropic receptor 5 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Dextroamphetamine results in increased expression of GRM5 mRNA]; Dactinomycin inhibits the reaction [Dextroamphetamine results in increased expression of GRM5 protein] |
CTD |
PMID:11665859 |
|
NCBI chr 1:141,310,069...141,884,980
Ensembl chr 1:141,312,368...141,882,274
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Dexamethasone results in increased expression of GSTA1 mRNA] |
CTD |
PMID:28483492 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases response to substance |
EXP |
GSTP1 protein results in decreased susceptibility to Dactinomycin |
CTD |
PMID:11455017 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
Dactinomycin results in increased expression of H2AX protein |
CTD |
PMID:31226288 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
multiple interactions decreases expression |
ISO |
Dactinomycin inhibits the reaction [Sodium Chloride results in increased expression of HBEGF mRNA] Dactinomycin results in decreased expression of HBEGF mRNA |
CTD |
PMID:26800359 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Hgf |
hepatocyte growth factor |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Berberine results in increased expression of HGF protein] |
CTD |
PMID:29408570 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of HIF1A protein] |
CTD |
PMID:12479793 PMID:19958256 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions decreases expression |
ISO EXP |
Dactinomycin inhibits the reaction [Ammonium Chloride results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Curcumin results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [ginsenoside Rb1 results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [ginsenoside Rb1 results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Lipid Peroxides results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Nitroprusside results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Oxygen results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Plant Extracts results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Potassium Dichromate results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Resveratrol results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [tricarbonyldichlororuthenium (II) dimer results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [tricarbonyldichlororuthenium (II) dimer results in increased expression of HMOX1 protein]; Dactinomycin results in decreased susceptibility to [surfactin peptide results in increased expression of HMOX1 mRNA]; HMOX1 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; NFKBIA protein inhibits the reaction [HMOX1 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]] Dactinomycin inhibits the reaction [fisetin results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [puerarin results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [puerarin results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Quercetin results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Triterpenes analog results in increased expression of HMOX1 protein] Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [cobaltous chloride results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Diclofenac results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [notoginsenoside R1 results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Quercetin results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Quercetin results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [resveratrol results in increased expression of HMOX1 mRNA] Dactinomycin results in decreased expression of HMOX1 protein |
CTD |
PMID:8764571 PMID:9747510 PMID:9808084 PMID:11880364 PMID:12763371 PMID:15118350 PMID:15582353 PMID:15588712 PMID:15876423 PMID:15965080 PMID:16647178 PMID:17002867 PMID:18332044 PMID:18357586 PMID:19781563 PMID:20060010 PMID:20833156 PMID:21840424 PMID:24437944 PMID:25239868 PMID:26283888 PMID:26385185 PMID:26968795 PMID:27867098 PMID:30076913 More...
|
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
multiple interactions affects localization |
ISO |
Dactinomycin affects the reaction [HNRNPA1 protein binds to CYP2A5 mRNA] Dactinomycin affects the localization of HNRNPA1 protein |
CTD |
PMID:12754101 |
|
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
|
|
G |
Homer3 |
homer scaffold protein 3 |
increases expression |
ISO |
Dactinomycin results in increased expression of HOMER3 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr16:19,132,177...19,142,739
Ensembl chr16:19,132,162...19,142,680
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions |
ISO |
Dactinomycin promotes the reaction [[Zinostatin co-treated with Glutathione] results in increased cleavage of HRAS gene] |
CTD |
PMID:9345283 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Bexarotene results in increased expression of HSD11B2 mRNA]; Dactinomycin inhibits the reaction [tributyltin results in increased expression of HSD11B2 mRNA]; Dactinomycin inhibits the reaction [triphenyltin chloride results in increased expression of HSD11B2 mRNA] |
CTD |
PMID:31927052 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of HSF1 mRNA]; Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of HSF1 protein] |
CTD |
PMID:30309986 |
|
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Dithiothreitol results in increased expression of HSP90B1 mRNA] |
CTD |
PMID:34244458 |
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions decreases expression |
EXP ISO |
Dactinomycin inhibits the reaction [Benzo(a)pyrene results in increased expression of HSPA5 mRNA]; Dactinomycin inhibits the reaction [lead acetate results in increased expression of HSPA5 mRNA]; Dactinomycin inhibits the reaction [Mercuric Chloride results in increased expression of HSPA5 mRNA]; Dactinomycin inhibits the reaction [Thapsigargin results in increased expression of HSPA5 mRNA]; Dactinomycin inhibits the reaction [Thapsigargin results in increased expression of HSPA5 protein] [Arsenic Trioxide co-treated with Dactinomycin] results in decreased expression of HSPA5 mRNA; [Arsenic Trioxide co-treated with Dactinomycin] results in increased expression of HSPA5 protein Dactinomycin results in decreased expression of HSPA5 mRNA |
CTD |
PMID:17915553 PMID:34560123 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Htr3a |
5-hydroxytryptamine receptor 3A |
multiple interactions |
ISO |
Dactinomycin promotes the reaction [Dronabinol results in decreased activity of HTR3A protein] |
CTD |
PMID:20800662 |
|
NCBI chr 8:49,242,018...49,254,475
Ensembl chr 8:49,242,020...49,254,389
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Tretinoin results in increased expression of ID1 mRNA] |
CTD |
PMID:16494909 |
|
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Ier3 |
immediate early response 3 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [afimoxifene results in increased expression of IER3 mRNA] |
CTD |
PMID:16849584 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ier5 |
immediate early response 5 |
increases expression |
ISO |
Dactinomycin results in increased expression of IER5 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr13:67,270,134...67,272,226
Ensembl chr13:67,270,135...67,272,227
|
|
G |
Ifna1 |
interferon, alpha 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [IFNA1 protein results in increased expression of TYMP mRNA] |
CTD |
PMID:15937643 |
|
NCBI chr 5:103,097,356...103,097,925
Ensembl chr 5:103,097,356...103,097,925
|
|
G |
Ifnb1 |
interferon beta 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [IFNB1 protein results in increased expression of TYMP mRNA] |
CTD |
PMID:15937643 |
|
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[Dactinomycin co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG mRNA; Dactinomycin inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of RNF213 mRNA]; Dactinomycin inhibits the reaction [IFNG protein results in increased expression of TYMP mRNA]; Dactinomycin inhibits the reaction [Tretinoin promotes the reaction [IFNG protein results in increased expression of IRF1 protein]] |
CTD |
PMID:15937643 PMID:16085646 PMID:26278786 PMID:29594315 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases response to substance |
ISO |
IGF1 protein results in decreased susceptibility to Dactinomycin |
CTD |
PMID:9525472 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Zymosan results in increased expression of IL10 mRNA] |
CTD |
PMID:17458858 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il11 |
interleukin 11 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Formaldehyde results in increased expression of IL11 mRNA] |
CTD |
PMID:22138297 |
|
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Glucose results in increased secretion of IL17A protein] |
CTD |
PMID:18310510 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [IL1A protein results in increased expression of FOS mRNA] |
CTD |
PMID:7564102 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO EXP |
Dactinomycin inhibits the reaction [IL1B protein results in increased abundance of Dinoprostone]; Dactinomycin inhibits the reaction [IL1B protein results in increased expression of PAPPA mRNA]; Dactinomycin inhibits the reaction [IL1B protein results in increased expression of TGFB1 mRNA]; Dactinomycin inhibits the reaction [IL1B protein results in increased secretion of TGFB1 protein]; Dactinomycin inhibits the reaction [IL1B results in increased abundance of Dinoprostone]; Dactinomycin inhibits the reaction [IL1B results in increased abundance of Nitric Oxide]; Dactinomycin inhibits the reaction [IL1B results in increased expression of BCL2 protein]; Dactinomycin inhibits the reaction [IL1B results in increased expression of MCL1 protein]; Dactinomycin inhibits the reaction [IL1B results in increased secretion of CSF2 protein] Dactinomycin inhibits the reaction [IL1B protein results in decreased expression of THRA mRNA alternative form]; Dactinomycin inhibits the reaction [IL1B protein results in decreased expression of THRA mRNA] Dactinomycin inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; Dactinomycin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] |
CTD |
PMID:9606035 PMID:11286988 PMID:12512699 PMID:16338976 PMID:16365456 PMID:16492401 PMID:17641275 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
[Dactinomycin co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il27ra |
interleukin 27 receptor subunit alpha |
increases expression |
ISO |
Dactinomycin results in increased expression of IL27RA mRNA |
CTD |
PMID:21527772 |
|
NCBI chr19:24,109,963...24,121,977
Ensembl chr19:24,109,972...24,121,938
|
|
G |
Il6 |
interleukin 6 |
decreases secretion |
ISO |
Dactinomycin results in decreased secretion of IL6 protein |
CTD |
PMID:11216681 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [bisphenol A results in increased secretion of INS1 protein]; Dactinomycin inhibits the reaction [nonylphenol results in increased secretion of INS1 protein] |
CTD |
PMID:15778011 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [[[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] co-treated with alitretinoin] results in increased expression of SLC27A1 mRNA] |
CTD |
PMID:10777552 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Irf1 |
interferon regulatory factor 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Tretinoin promotes the reaction [IFNG protein results in increased expression of IRF1 protein]]; Dactinomycin inhibits the reaction [Tretinoin results in increased expression of IRF1 mRNA] |
CTD |
PMID:16085646 PMID:16636311 |
|
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Itga2b |
integrin subunit alpha 2b |
increases expression |
ISO |
Dactinomycin results in increased expression of ITGA2B mRNA |
CTD |
PMID:21527772 |
|
NCBI chr10:87,408,532...87,426,055
Ensembl chr10:87,408,536...87,426,168
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Ethanol results in increased expression of ITPR1 mRNA]; Dactinomycin inhibits the reaction [linsidomine results in increased expression of ITPR1 mRNA] |
CTD |
PMID:17241155 |
|
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
|
|
G |
Jak2 |
Janus kinase 2 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Aldosterone results in increased phosphorylation of JAK2 protein] |
CTD |
PMID:15932931 |
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions decreases expression |
ISO EXP |
Dactinomycin inhibits the reaction [beryllium sulfate results in increased expression of JUN mRNA]; Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of JUN mRNA] Dactinomycin inhibits the reaction [Cadmium results in increased expression of JUN mRNA]; Dactinomycin inhibits the reaction [Fructose results in increased expression of JUN mRNA]; Dactinomycin inhibits the reaction [Glucose results in increased expression of JUN mRNA] Dactinomycin results in decreased expression of JUN mRNA |
CTD |
PMID:1696944 PMID:11123204 PMID:11353138 PMID:11568973 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kif1a |
kinesin family member 1A |
increases expression |
ISO |
Dactinomycin results in increased expression of KIF1A mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 9:93,563,033...93,647,412
Ensembl chr 9:93,563,045...93,647,480
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [[KRAS protein mutant form affects the susceptibility to vemurafenib] which results in increased expression of TNFRSF10B mRNA] |
CTD |
PMID:27222248 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Krt80 |
keratin 80 |
increases expression |
ISO |
Dactinomycin results in increased expression of KRT80 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 7:132,463,216...132,485,134
Ensembl chr 7:132,463,218...132,485,508
|
|
G |
Lamc2 |
laminin subunit gamma 2 |
increases expression |
ISO |
Dactinomycin results in increased expression of LAMC2 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
|
|
G |
Ldlr |
low density lipoprotein receptor |
multiple interactions decreases expression |
ISO |
Ascorbic Acid inhibits the reaction [Dactinomycin results in decreased expression of LDLR mRNA] |
CTD |
PMID:32913121 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lep |
leptin |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [LEP protein results in increased expression of COL1A2 mRNA] |
CTD |
PMID:12704794 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lgals3 |
galectin 3 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein] |
CTD |
PMID:21821001 |
|
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
|
|
G |
Lgals7 |
galectin 7 |
increases expression |
ISO |
Dactinomycin results in increased expression of LGALS7 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 1:84,148,612...84,152,016
Ensembl chr 1:84,150,252...84,152,015
|
|
G |
Lmnb1 |
lamin B1 |
decreases expression |
ISO |
Dactinomycin results in decreased expression of LMNB1 mRNA |
CTD |
PMID:16001973 |
|
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Ethanol results in increased expression of MAP1LC3B protein] |
CTD |
PMID:24095927 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
decreases expression |
ISO |
Dactinomycin results in decreased expression of MAP2K4 mRNA |
CTD |
PMID:16001973 |
|
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
|
|
G |
Map3k7 |
mitogen activated protein kinase kinase kinase 7 |
decreases expression |
ISO |
Dactinomycin results in decreased expression of MAP3K7 mRNA |
CTD |
PMID:16001973 |
|
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases expression |
ISO EXP |
PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein] Dactinomycin results in increased expression of MAPK1 protein PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein] |
CTD |
PMID:14640974 PMID:15959627 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases expression |
ISO EXP |
PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein] PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein] Dactinomycin results in increased expression of MAPK3 protein |
CTD |
PMID:14640974 PMID:15959627 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
decreases expression multiple interactions |
ISO |
Dactinomycin results in decreased expression of MCL1 mRNA Dactinomycin inhibits the reaction [IL1B results in increased expression of MCL1 protein]; Dactinomycin inhibits the reaction [TNF results in increased expression of MCL1 protein]; Quercetin promotes the reaction [Dactinomycin results in decreased expression of MCL1 mRNA] |
CTD |
PMID:16492401 PMID:21750559 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Mir21 |
microRNA 21 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Dehydroepiandrosterone results in increased expression of MIR21 mRNA]; Dactinomycin inhibits the reaction [Dihydrotestosterone results in increased expression of MIR21 mRNA]; Dactinomycin inhibits the reaction [Estradiol results in decreased expression of MIR21 mRNA]; Dactinomycin inhibits the reaction [fludioxonil results in increased expression of MIR21 mRNA]; Dactinomycin inhibits the reaction [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of MIR21 mRNA] |
CTD |
PMID:19264808 PMID:23052036 PMID:25969534 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir22 |
microRNA 22 |
multiple interactions |
ISO |
[Dactinomycin co-treated with Dehydroepiandrosterone] results in increased expression of MIR22 mRNA; Dactinomycin promotes the reaction [Dehydroepiandrosterone results in increased expression of MIR22 mRNA] |
CTD |
PMID:25969534 |
|
NCBI chr10:60,307,039...60,307,133
Ensembl chr10:60,307,039...60,307,133
|
|
G |
Mllt11 |
MLLT11, transcription factor 7 cofactor |
increases expression |
ISO |
Dactinomycin results in increased expression of MLLT11 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 2:182,795,790...182,804,960
Ensembl chr 2:182,795,790...182,797,199
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of MMP1 protein] |
CTD |
PMID:19136476 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
ISO |
Dactinomycin inhibits the reaction [arsenic trioxide results in increased expression of MMP9 mRNA] Dactinomycin results in decreased expression of MMP9 mRNA |
CTD |
PMID:24956101 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mn1 |
MN1 proto-oncogene, transcriptional regulator |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Calcitriol results in increased expression of MN1 mRNA] |
CTD |
PMID:15890672 |
|
NCBI chr12:45,181,794...45,220,959
Ensembl chr12:45,183,085...45,221,651
|
|
G |
Mrpl41 |
mitochondrial ribosomal protein L41 |
multiple interactions |
ISO |
Dactinomycin promotes the reaction [MRPL41 protein results in increased stability of and affects the localization of TP53 protein] |
CTD |
PMID:16024796 |
|
NCBI chr 3:7,780,658...7,781,576
Ensembl chr 3:7,779,143...7,782,818
|
|
G |
Mt2A |
metallothionein 2A |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [zinc chloride results in increased expression of MT2A mRNA] |
CTD |
PMID:17234632 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [pirinixic acid results in increased expression of MTTP mRNA] |
CTD |
PMID:15537571 |
|
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression multiple interactions |
ISO EXP |
Dactinomycin results in decreased expression of MYC mRNA Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of MYC mRNA] Dactinomycin inhibits the reaction [Cadmium results in increased expression of MYC mRNA] |
CTD |
PMID:1696944 PMID:11353138 PMID:16001973 PMID:21527772 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Mylk |
myosin light chain kinase |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [TNF protein results in increased expression of MYLK mRNA]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of MYLK protein] |
CTD |
PMID:15701621 |
|
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
|
|
G |
Nav2 |
neuron navigator 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Tretinoin results in increased expression of NAV2 mRNA] |
CTD |
PMID:16688769 |
|
NCBI chr 1:98,957,629...99,322,339
Ensembl chr 1:98,663,759...99,322,337
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Benzo(a)pyrene results in increased expression of NCF1 mRNA] |
CTD |
PMID:19559082 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
multiple interactions |
ISO |
[nickel chloride co-treated with Dactinomycin] results in increased stability of NDRG1 mRNA; [Oxygen deficiency co-treated with Dactinomycin] results in increased stability of NDRG1 mRNA |
CTD |
PMID:10646848 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated 9 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Tretinoin results in increased expression of NEDD9 mRNA] |
CTD |
PMID:16688769 |
|
NCBI chr17:23,289,793...23,468,026
Ensembl chr17:23,282,326...23,468,019
|
|
G |
Neto2 |
neuropilin and tolloid like 2 |
increases expression |
ISO |
Dactinomycin results in increased expression of NETO2 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr19:21,344,299...21,415,524
Ensembl chr19:21,344,289...21,417,023
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein]; Dactinomycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NFE2L2 mRNA] |
CTD |
PMID:22019695 PMID:24632381 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
decreases expression multiple interactions |
ISO |
Dactinomycin results in decreased expression of NFKB1 mRNA [RELA protein co-treated with NFKB1 protein] inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] |
CTD |
PMID:11880364 PMID:16001973 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
NFKBIA protein inhibits the reaction [HMOX1 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]] |
CTD |
PMID:11880364 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Ngf |
nerve growth factor |
multiple interactions decreases expression |
EXP |
Dactinomycin inhibits the reaction [9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2 analog results in increased expression of NGF mRNA]; Dactinomycin inhibits the reaction [NEPP11 compound results in increased expression of NGF mRNA] Dactinomycin results in decreased expression of NGF mRNA |
CTD |
PMID:22982731 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Asbestos, Crocidolite results in increased expression of NLRP3 mRNA] |
CTD |
PMID:23937860 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
EXP ISO |
Dactinomycin inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA] Dactinomycin inhibits the reaction [[Raloxifene Hydrochloride co-treated with 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid] results in increased expression of NOS2 protein] |
CTD |
PMID:11286988 PMID:28138957 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nppc |
natriuretic peptide C |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Estradiol results in increased expression of NPPC mRNA] |
CTD |
PMID:9435603 |
|
NCBI chr 9:87,320,051...87,324,251
Ensembl chr 9:87,320,051...87,324,251
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
ISO EXP |
Dactinomycin inhibits the reaction [Biological Products results in increased expression of NQO1 mRNA]; Dactinomycin inhibits the reaction [Itraconazole results in increased expression of NQO1 mRNA]; Dactinomycin inhibits the reaction [Ketoconazole results in increased expression of NQO1 mRNA]; Dactinomycin inhibits the reaction [Lead results in increased expression of NQO1 mRNA]; Dactinomycin inhibits the reaction [Mercury results in increased expression of NQO1 mRNA]; Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]; Dactinomycin promotes the reaction [Chromium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]] Dactinomycin inhibits the reaction [notoginsenoside R1 results in increased expression of NQO1 protein] |
CTD |
PMID:16243960 PMID:17923278 PMID:18474416 PMID:22570534 PMID:24437944 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr0b1 |
nuclear receptor subfamily 0, group B, member 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Bucladesine results in decreased expression of NR0B1 mRNA]; Dactinomycin inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of NR0B1 mRNA] |
CTD |
PMID:18787026 |
|
NCBI chr X:50,756,886...50,761,014
Ensembl chr X:50,756,886...50,761,011
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Fenofibrate results in increased expression of NR0B2 mRNA] |
CTD |
PMID:19593819 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
EXP ISO |
Dactinomycin inhibits the reaction [Clofibrate results in increased expression of NR1I2 protein]; Dactinomycin inhibits the reaction [Dexamethasone results in increased expression of NR1I2 mRNA]; Dactinomycin inhibits the reaction [perfluorodecanoic acid results in increased expression of NR1I2 protein] Dactinomycin inhibits the reaction [ochratoxin A results in decreased expression of NR1I2 mRNA] |
CTD |
PMID:15826607 PMID:20599767 PMID:26341324 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Dexamethasone affects the localization of NR3C1 protein]; Dactinomycin inhibits the reaction [Dexamethasone binds to NR3C1 protein]; Dactinomycin inhibits the reaction [Dexamethasone results in increased degradation of NR3C1 protein] |
CTD |
PMID:21569845 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Nthl1 |
nth-like DNA glycosylase 1 |
decreases expression |
ISO |
Dactinomycin results in decreased expression of NTHL1 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr10:13,655,791...13,661,958
Ensembl chr10:13,655,785...13,661,957
|
|
G |
Opa1 |
OPA1, mitochondrial dynamin like GTPase |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [15-deoxyprostaglandin J2 results in increased expression of OPA1 protein alternative form] |
CTD |
PMID:20678484 |
|
NCBI chr11:71,108,100...71,185,170
Ensembl chr11:71,109,873...71,185,109
|
|
G |
Pappa |
pappalysin |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [IL1B protein results in increased expression of PAPPA mRNA]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of PAPPA mRNA] |
CTD |
PMID:16338976 |
|
NCBI chr 5:78,497,660...78,735,873
Ensembl chr 5:78,498,300...78,730,666
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
[TNF co-treated with Dactinomycin] results in increased cleavage of PARP1 protein; Dactinomycin promotes the reaction [TNF results in increased cleavage of PARP1 protein]; PLD1 protein inhibits the reaction [Dactinomycin results in increased cleavage of PARP1 protein] PLD2 protein inhibits the reaction [Dactinomycin results in increased cleavage of PARP1 protein] |
CTD |
PMID:14640974 PMID:16492401 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Hydrocortisone results in increased activity of PCK1 protein] |
CTD |
PMID:6476976 |
|
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression multiple interactions |
EXP ISO |
Dactinomycin results in decreased expression of PCNA protein Dactinomycin inhibits the reaction [Vitamin K 3 results in decreased expression of PCNA protein] |
CTD |
PMID:15959627 PMID:21533478 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Plat |
plasminogen activator, tissue type |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Catechin results in increased expression of PLAT mRNA]; Dactinomycin inhibits the reaction [Quercetin results in increased expression of PLAT mRNA]; Dactinomycin inhibits the reaction [Resveratrol results in increased expression of PLAT mRNA] |
CTD |
PMID:11236827 |
|
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Plau |
plasminogen activator, urokinase |
multiple interactions increases expression |
ISO |
Dactinomycin inhibits the reaction [Catechin results in increased expression of PLAU mRNA]; Dactinomycin inhibits the reaction [Quercetin results in increased expression of PLAU mRNA]; Dactinomycin inhibits the reaction [resveratrol results in increased expression of PLAU mRNA] Dactinomycin results in increased expression of PLAU mRNA |
CTD |
PMID:11236827 PMID:21527772 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Pld1 |
phospholipase D1 |
multiple interactions |
ISO |
PLD1 protein inhibits the reaction [Dactinomycin results in increased cleavage of PARP1 protein]; PLD1 protein inhibits the reaction [Dactinomycin results in increased cleavage of PRKCD protein]; PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of AKT1 protein]; PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] |
CTD |
PMID:14640974 |
|
NCBI chr 2:110,849,205...111,047,304
Ensembl chr 2:110,893,608...111,047,692
|
|
G |
Pld2 |
phospholipase D2 |
multiple interactions |
ISO |
PLD2 protein inhibits the reaction [Dactinomycin results in increased cleavage of PARP1 protein]; PLD2 protein inhibits the reaction [Dactinomycin results in increased cleavage of PRKCD protein]; PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of AKT1 protein]; PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] |
CTD |
PMID:14640974 |
|
NCBI chr10:55,256,326...55,274,192
Ensembl chr10:55,256,359...55,272,808
|
|
G |
Polh |
DNA polymerase eta |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [fotemustine results in increased expression of POLH mRNA] |
CTD |
PMID:25125662 |
|
NCBI chr 9:14,778,355...14,813,210
Ensembl chr 9:14,777,888...14,812,723
|
|
G |
Polr2a |
RNA polymerase II subunit A |
decreases phosphorylation multiple interactions increases phosphorylation |
ISO |
Dactinomycin results in decreased phosphorylation of POLR2A protein [Dactinomycin co-treated with sodium arsenite] results in increased phosphorylation of POLR2A protein Dactinomycin results in increased phosphorylation of POLR2A protein |
CTD |
PMID:8126066 |
|
NCBI chr10:54,452,438...54,478,486
Ensembl chr10:54,452,441...54,478,455
|
|
G |
Pomt1 |
protein-O-mannosyltransferase 1 |
increases expression |
ISO |
Dactinomycin results in increased expression of POMT1 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 3:15,520,717...15,538,579
Ensembl chr 3:15,520,481...15,538,581
|
|
G |
Prdx1 |
peroxiredoxin 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [sodium arsenate results in increased expression of PRDX1 mRNA]; Dactinomycin inhibits the reaction [sodium arsenate results in increased expression of PRDX1 protein] |
CTD |
PMID:11796722 |
|
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Prdx6 |
peroxiredoxin 6 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Hydrogen Peroxide results in increased expression of PRDX6 mRNA]; Dactinomycin inhibits the reaction [Paraquat results in increased expression of PRDX6 mRNA] |
CTD |
PMID:12851211 |
|
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
|
|
G |
Prkcd |
protein kinase C, delta |
multiple interactions |
ISO |
PLD1 protein inhibits the reaction [Dactinomycin results in increased cleavage of PRKCD protein] PLD2 protein inhibits the reaction [Dactinomycin results in increased cleavage of PRKCD protein] |
CTD |
PMID:14640974 |
|
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
|
|
G |
Prl |
prolactin |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [PRL protein results in increased expression of SLC30A2 mRNA] |
CTD |
PMID:19494234 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Procr |
protein C receptor |
increases expression |
ISO |
Dactinomycin results in increased expression of PROCR mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 3:144,254,596...144,258,863
Ensembl chr 3:144,254,380...144,258,903
|
|
G |
Prom1 |
prominin 1 |
decreases expression multiple interactions |
ISO |
Dactinomycin results in decreased expression of PROM1 mRNA Dactinomycin results in decreased expression of and affects the localization of PROM1 protein |
CTD |
PMID:31226288 |
|
NCBI chr14:66,989,545...67,094,534
Ensembl chr14:66,990,160...67,094,527
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions decreases expression increases degradation |
ISO EXP |
Dactinomycin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Dactinomycin inhibits the reaction [Sodium Fluoride results in increased expression of PTGS2 mRNA]; Dactinomycin inhibits the reaction [Tretinoin results in increased expression of PTGS2 protein]; Dactinomycin inhibits the reaction [Zinc results in increased expression of PTGS2 mRNA]; Dactinomycin inhibits the reaction [Zinc results in increased expression of PTGS2 protein] Dactinomycin inhibits the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; Dactinomycin inhibits the reaction [Corticosterone results in increased expression of PTGS2 protein]; Dactinomycin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] Dactinomycin results in decreased expression of PTGS2 mRNA CDKN1B protein affects the reaction [Dactinomycin results in increased degradation of PTGS2 mRNA]; Dactinomycin inhibits the reaction [nickel chloride results in increased expression of PTGS2 protein]; Dactinomycin inhibits the reaction [nickel sulfide results in increased expression of PTGS2 protein]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] |
CTD |
PMID:9576062 PMID:11286988 PMID:16894348 PMID:17065197 PMID:18513776 PMID:18650268 PMID:19376214 PMID:23639288 PMID:24967690 More...
|
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
decreases expression |
EXP |
Dactinomycin results in decreased expression of PTK2 protein |
CTD |
PMID:15959627 |
|
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
|
|
G |
Rad51 |
RAD51 recombinase |
multiple interactions decreases expression |
ISO |
tetrachlorobenzoquinone promotes the reaction [Dactinomycin results in decreased expression of RAD51 mRNA] |
CTD |
PMID:27989139 |
|
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
decreases expression |
EXP |
Dactinomycin results in decreased expression of RAF1 protein |
CTD |
PMID:15959627 |
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Rel |
REL proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
[RELA protein co-treated with REL protein] inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] |
CTD |
PMID:11880364 |
|
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
[RELA protein co-treated with NFKB1 protein] inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; [RELA protein co-treated with REL protein] inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; RELA protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] |
CTD |
PMID:11880364 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ren |
renin |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Dobutamine results in increased secretion of REN protein]; Dactinomycin inhibits the reaction [Terbutaline results in increased secretion of REN protein] |
CTD |
PMID:9203624 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Retsat |
retinol saturase |
increases expression |
ISO |
Dactinomycin results in increased expression of RETSAT mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 4:104,653,306...104,662,069
Ensembl chr 4:104,653,155...104,668,310
|
|
G |
Rhob |
ras homolog family member B |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [cytotoxic necrotizing factor type 1 results in increased expression of RHOB mRNA]; Dactinomycin inhibits the reaction [cytotoxic necrotizing factor type 1 results in increased expression of RHOB protein] |
CTD |
PMID:23732113 |
|
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
|
|
G |
Ripply3 |
ripply transcriptional repressor 3 |
increases expression |
ISO |
Dactinomycin results in increased expression of RIPPLY3 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr11:33,648,471...33,656,587
Ensembl chr11:33,648,486...33,656,584
|
|
G |
Rnf213 |
ring finger protein 213 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of RNF213 mRNA] |
CTD |
PMID:26278786 |
|
NCBI chr10:104,656,329...104,755,669
Ensembl chr10:104,656,883...104,757,918
|
|
G |
Ros1 |
ROS proto-oncogene 1 , receptor tyrosine kinase |
increases expression |
ISO |
Dactinomycin results in increased expression of ROS1 mRNA |
CTD |
PMID:16001973 |
|
NCBI chr20:31,432,636...31,583,998
Ensembl chr20:31,432,637...31,583,865
|
|
G |
Rpl34 |
ribosomal protein L34 |
increases expression |
ISO |
Dactinomycin results in increased expression of RPL34 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 2:219,284,373...219,288,108
Ensembl chr 2:219,284,382...219,288,111
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
ISO |
PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] |
CTD |
PMID:14640974 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Rras |
RAS related |
increases expression |
ISO |
Dactinomycin results in increased expression of RRAS mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 1:95,500,582...95,504,362
Ensembl chr 1:95,500,566...95,504,357
|
|
G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [N(1),N(11)-diethylnorspermine results in increased expression of SAT1 mRNA] |
CTD |
PMID:16637064 |
|
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
|
|
G |
Scd |
stearoyl-CoA desaturase |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [ciprofibrate results in increased expression of SCD1 mRNA] |
CTD |
PMID:11172741 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Scnn1b |
sodium channel epithelial 1 subunit beta |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Dexamethasone results in increased expression of SCNN1B mRNA] |
CTD |
PMID:10942727 |
|
NCBI chr 1:176,430,063...176,484,451
Ensembl chr 1:176,430,103...176,484,451
|
|
G |
Scnn1g |
sodium channel epithelial 1 subunit gamma |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Dexamethasone results in increased expression of SCNN1G mRNA] |
CTD |
PMID:10942727 |
|
NCBI chr 1:176,304,942...176,338,816
Ensembl chr 1:176,304,942...176,338,816
|
|
G |
Sdc3 |
syndecan 3 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Estradiol results in increased expression of SDC3 mRNA] |
CTD |
PMID:11024013 |
|
NCBI chr 5:142,965,659...142,998,390
Ensembl chr 5:142,965,591...142,996,480
|
|
G |
Sesn2 |
sestrin 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [erastin results in increased expression of SESN2 mRNA] |
CTD |
PMID:31323261 |
|
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
|
|
G |
Sfn |
stratifin |
increases expression |
ISO |
Dactinomycin results in increased expression of SFN mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of SGK1 mRNA]; Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of SGK1 protein] |
CTD |
PMID:25128767 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|
G |
Shh |
sonic hedgehog signaling molecule |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [SHH protein alternative form results in increased expression of ABCG2 protein] |
CTD |
PMID:21625222 |
|
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO |
Dactinomycin affects the reaction [antimony trichloride results in decreased expression of SIRT1 mRNA] TAF15 mRNA inhibits the reaction [Dactinomycin results in decreased expression of SIRT1 mRNA] |
CTD |
PMID:30055241 PMID:35307376 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc25a14 |
solute carrier family 25 member 14 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SLC25A14 mRNA]; Dactinomycin inhibits the reaction [Dopamine results in increased expression of SLC25A14 mRNA] |
CTD |
PMID:20600837 |
|
NCBI chr X:127,807,630...127,845,823
Ensembl chr X:127,807,449...127,845,823
|
|
G |
Slc27a1 |
solute carrier family 27 member 1 |
multiple interactions |
ISO EXP |
Dactinomycin inhibits the reaction [[[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] co-treated with alitretinoin] results in increased expression of SLC27A1 mRNA] Dactinomycin inhibits the reaction [alitretinoin results in increased expression of SLC27A1 mRNA] |
CTD |
PMID:10777552 |
|
NCBI chr16:18,278,984...18,300,173
Ensembl chr16:18,278,984...18,296,063
|
|
G |
Slc2a2 |
solute carrier family 2 member 2 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Fructose results in increased expression of SLC2A2 mRNA]; Dactinomycin inhibits the reaction [Glucose results in increased expression of SLC2A2 mRNA] |
CTD |
PMID:12787936 |
|
NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
|
|
G |
Slc2a5 |
solute carrier family 2 member 5 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Fructose promotes the reaction [SLC2A5 protein results in increased uptake of Fructose]]; Dactinomycin inhibits the reaction [Fructose results in increased expression of SLC2A5 mRNA] |
CTD |
PMID:11123204 |
|
NCBI chr 5:160,583,055...160,609,994
Ensembl chr 5:160,583,234...160,611,106
|
|
G |
Slc30a2 |
solute carrier family 30 member 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [PRL protein results in increased expression of SLC30A2 mRNA] |
CTD |
PMID:19494234 |
|
NCBI chr 5:146,559,733...146,571,957
Ensembl chr 5:146,559,733...146,571,956
|
|
G |
Slc30a5 |
solute carrier family 30 member 5 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [zinc chloride results in decreased expression of SLC30A5 mRNA] |
CTD |
PMID:17234632 |
|
NCBI chr 2:31,945,745...31,975,969
Ensembl chr 2:31,945,729...31,975,934
|
|
G |
Slc39a10 |
solute carrier family 39 member 10 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SLC39A10 mRNA] |
CTD |
PMID:21738690 |
|
NCBI chr 9:54,836,841...54,960,325
Ensembl chr 9:54,876,141...54,960,325
|
|
G |
Slc39a4 |
solute carrier family 39 member 4 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Zinc deficiency results in increased expression of SLC39A4 mRNA]; Dactinomycin inhibits the reaction [Zinc results in decreased expression of SLC39A4 mRNA] |
CTD |
PMID:18020946 |
|
NCBI chr 7:108,333,368...108,337,553
Ensembl chr 7:108,333,381...108,337,553
|
|
G |
Slc3a2 |
solute carrier family 3 member 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Vehicle Emissions results in increased expression of SLC3A2 mRNA] |
CTD |
PMID:26621329 |
|
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
|
|
G |
Slc40a1 |
solute carrier family 40 member 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Cadmium results in increased expression of SLC40A1 mRNA] |
CTD |
PMID:20090884 |
|
NCBI chr 9:48,033,526...48,053,876
Ensembl chr 9:48,033,526...48,051,481
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
decreases expression |
ISO |
Dactinomycin results in decreased expression of SLC7A11 protein |
CTD |
PMID:31226288 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Vehicle Emissions results in increased expression of SLC7A5 mRNA] |
CTD |
PMID:26621329 |
|
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Smpd1 |
sphingomyelin phosphodiesterase 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [diethyl maleate results in increased expression of SMPD1 mRNA] |
CTD |
PMID:25762726 |
|
NCBI chr 1:159,892,946...159,896,789
Ensembl chr 1:159,892,859...159,896,794
|
|
G |
Snca |
synuclein alpha |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [FGF2 protein results in increased expression of SNCA protein] |
CTD |
PMID:12562524 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Cycloheximide results in increased expression of SOCS3 mRNA] |
CTD |
PMID:23237828 |
|
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
ISO EXP |
Dactinomycin inhibits the reaction [Arachidonic Acid results in increased expression of SOD2 mRNA]; Dactinomycin inhibits the reaction [Paclitaxel results in increased expression of SOD2 mRNA]; Dactinomycin inhibits the reaction [SOD2 protein results in increased expression of SOD2 mRNA]; Dactinomycin inhibits the reaction [Vinblastine results in increased expression of SOD2 mRNA]; Dactinomycin inhibits the reaction [Vincristine results in increased expression of SOD2 mRNA]; SOD2 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] Dactinomycin inhibits the reaction [[2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of Nitric Oxide] which results in increased expression of SOD2 mRNA] Dactinomycin inhibits the reaction [polysaccharide-K results in increased expression of SOD2] |
CTD |
PMID:9852137 PMID:11154046 PMID:11880364 PMID:12031898 PMID:14996425 PMID:15683720 More...
|
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sos1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
decreases expression |
ISO |
Dactinomycin results in decreased expression of SOS1 mRNA |
CTD |
PMID:16001973 |
|
NCBI chr 6:14,533,870...14,613,348
Ensembl chr 6:14,533,360...14,611,107
|
|
G |
Sox17 |
SRY-box transcription factor 17 |
decreases localization |
ISO |
Dactinomycin results in decreased localization of SOX17 protein |
CTD |
PMID:24154490 |
|
NCBI chr 5:15,016,660...15,022,228
Ensembl chr 5:15,016,731...15,022,228
|
|
G |
Spata18 |
spermatogenesis associated 18 |
increases expression |
ISO |
Dactinomycin results in increased expression of SPATA18 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr14:34,531,931...34,558,671
Ensembl chr14:34,531,061...34,558,687
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Ethanol results in decreased expression of SQSTM1 protein] Dactinomycin inhibits the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone results in increased expression of SQSTM1 mRNA] |
CTD |
PMID:24095927 PMID:25301941 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
increases expression |
ISO |
Dactinomycin results in increased expression of STAT1 mRNA |
CTD |
PMID:16001973 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stmn3 |
stathmin 3 |
increases expression |
ISO |
Dactinomycin results in increased expression of STMN3 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 3:168,416,810...168,424,946
Ensembl chr 3:168,416,810...168,425,056
|
|
G |
Stom |
stomatin |
increases expression |
ISO |
Dactinomycin results in increased expression of STOM mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 3:18,645,058...18,667,343
Ensembl chr 3:18,644,378...18,667,354
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Gallic Acid results in increased expression of SULT1A1 mRNA] |
CTD |
PMID:16308312 |
|
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G |
Taf15 |
TATA-box binding protein associated factor 15 |
multiple interactions |
ISO |
TAF15 mRNA inhibits the reaction [Dactinomycin results in decreased expression of SIRT1 mRNA] |
CTD |
PMID:35307376 |
|
NCBI chr10:68,272,921...68,304,951
Ensembl chr10:68,272,969...68,304,949
|
|
G |
Tap1 |
transporter 1, ATP binding cassette subfamily B member |
increases expression |
ISO |
Dactinomycin results in increased expression of TAP1 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
|
|
G |
Tat |
tyrosine aminotransferase |
multiple interactions |
EXP ISO |
Dactinomycin inhibits the reaction [Dexamethasone results in increased activity of TAT protein]; Dactinomycin inhibits the reaction [Dexamethasone results in increased expression of TAT mRNA]; Dactinomycin inhibits the reaction [Ursodeoxycholic Acid promotes the reaction [Dexamethasone results in increased activity of TAT protein]] |
CTD |
PMID:9398635 PMID:20599767 PMID:28483492 |
|
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
|
|
G |
Tbx3 |
T-box transcription factor 3 |
multiple interactions |
ISO |
actinomycin D inhibits the reaction [all-trans-retinoic acid increases expression of TBX3 mRNA in melanoma cells] |
RGD |
PMID:22535523 |
RGD:151361117 |
NCBI chr12:36,879,924...36,894,849
Ensembl chr12:36,881,445...36,893,708
|
|
G |
Tcf4 |
transcription factor 4 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of TCF4 mRNA] |
CTD |
PMID:20459685 |
|
NCBI chr18:62,941,739...63,288,126
Ensembl chr18:62,943,782...63,284,425
|
|
G |
Tdo2 |
tryptophan 2,3-dioxygenase |
affects activity |
EXP |
Dactinomycin affects the activity of TDO2 protein |
CTD |
PMID:7306070 |
|
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
|
|
G |
Testin |
testin gene |
multiple interactions decreases secretion |
EXP |
Dactinomycin inhibits the reaction [Bucladesine results in decreased expression of TESTIN mRNA]; Dactinomycin inhibits the reaction [lonidamine results in increased expression of TESTIN mRNA]; Dactinomycin inhibits the reaction [lonidamine results in increased secretion of TESTIN protein] Dactinomycin results in decreased secretion of TESTIN protein |
CTD |
PMID:11090432 |
|
NCBI chr17:3,824,222...3,859,385
Ensembl chr17:3,846,899...3,859,385
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [IL1B protein results in increased expression of TGFB1 mRNA]; Dactinomycin inhibits the reaction [IL1B protein results in increased secretion of TGFB1 protein]; Dactinomycin inhibits the reaction [TGFB1 protein results in decreased expression of AHR mRNA] |
CTD |
PMID:9145908 PMID:16365456 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [TGFB2 protein results in increased expression of COL1A1 mRNA]; Dactinomycin inhibits the reaction [TGFB2 protein results in increased expression of FN1 mRNA] |
CTD |
PMID:18253093 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Thra |
thyroid hormone receptor alpha |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [IL1B protein results in decreased expression of THRA mRNA alternative form]; Dactinomycin inhibits the reaction [IL1B protein results in decreased expression of THRA mRNA] |
CTD |
PMID:17641275 |
|
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
|
|
G |
Tiparp |
TCDD-inducible poly(ADP-ribose) polymerase |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA] |
CTD |
PMID:12147270 |
|
NCBI chr 2:149,753,682...149,780,327
Ensembl chr 2:149,753,682...149,780,327
|
|
G |
Tmeff2 |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Dihydrotestosterone results in increased expression of TMEFF2 mRNA] |
CTD |
PMID:23405127 |
|
NCBI chr 9:50,445,947...50,733,473
Ensembl chr 9:50,436,079...50,733,475
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases response to substance |
ISO EXP |
[Dactinomycin co-treated with TNF protein] results in increased expression of BNIP3 mRNA; Dactinomycin inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA]; Dactinomycin promotes the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [lipoteichoic acid results in increased expression of TNF mRNA]] Dactinomycin results in increased susceptibility to TNF protein [RELA protein co-treated with NFKB1 protein] inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; [RELA protein co-treated with REL protein] inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; [TNF co-treated with Dactinomycin] results in increased activity of CASP3 protein; [TNF co-treated with Dactinomycin] results in increased activity of CASP7 protein; [TNF co-treated with Dactinomycin] results in increased cleavage of PARP1 protein; [TNF protein co-treated with Dactinomycin] results in decreased expression of TP53 protein; [TNF protein co-treated with Dactinomycin] results in increased activity of CASP3 protein; [TNF protein co-treated with Dactinomycin] results in increased activity of CASP7 protein; BCL2 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; BCL2A1 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; BIRC3 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; Dactinomycin inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of RNF213 mRNA]; Dactinomycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF protein]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of CCL11 mRNA]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of HIF1A protein]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of MYLK mRNA]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of MYLK protein]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of PAPPA mRNA]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; Dactinomycin inhibits the reaction [TNF results in increased abundance of Nitric Oxide]; Dactinomycin inhibits the reaction [TNF results in increased expression of BCL2 protein]; Dactinomycin inhibits the reaction [TNF results in increased expression of MCL1 protein]; Dactinomycin inhibits the reaction [Zinc deficiency promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF protein]]; Dactinomycin promotes the reaction [TNF results in increased activity of CASP3 protein]; Dactinomycin promotes the reaction [TNF results in increased activity of CASP7 protein]; Dactinomycin promotes the reaction [TNF results in increased cleavage of PARP1 protein]; HMOX1 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; NFKBIA protein inhibits the reaction [HMOX1 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]]; RELA protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; SOD2 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; TNFAIP3 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] [Dactinomycin co-treated with TNF protein] results in increased activity of CASP3 protein; Dactinomycin inhibits the reaction [TNF protein results in increased expression of EDNRB mRNA] |
CTD |
PMID:9576062 PMID:10100995 PMID:11592958 PMID:11880364 PMID:12479793 PMID:12812920 PMID:15531761 PMID:15701621 PMID:16338976 PMID:16492401 PMID:18845389 PMID:21496118 PMID:22207076 PMID:23300732 PMID:23968587 PMID:26278786 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
multiple interactions |
ISO |
TNFAIP3 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] |
CTD |
PMID:11880364 |
|
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tnfrsf22 |
tumor necrosis factor receptor superfamily, member 22 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [tetrachlorobenzoquinone results in increased expression of TNFRSF10B mRNA] |
CTD |
PMID:27484784 |
|
NCBI chr 1:198,840,452...198,860,713
Ensembl chr 1:198,840,453...198,856,309
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
multiple interactions |
ISO |
[Dactinomycin co-treated with TNFSF10 protein] results in increased activity of CASP7 protein; [Dactinomycin co-treated with TNFSF10 protein] results in increased activity of CASP9 protein; [Dactinomycin co-treated with TNFSF10 protein] results in increased expression of AIFM1 protein |
CTD |
PMID:17707539 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tnfsf9 |
TNF superfamily member 9 |
increases expression |
ISO |
Dactinomycin results in increased expression of TNFSF9 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 9:1,944,017...1,946,351
Ensembl chr 9:1,944,017...1,946,345
|
|
G |
Top1 |
DNA topoisomerase I |
increases activity |
ISO |
Dactinomycin results in increased activity of TOP1 protein |
CTD |
PMID:2164630 |
|
NCBI chr 3:149,293,469...149,376,618
Ensembl chr 3:149,293,403...149,376,623
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression increases activity |
ISO |
[TNF protein co-treated with Dactinomycin] results in decreased expression of TP53 protein; Cadmium Chloride inhibits the reaction [Dactinomycin results in increased expression of and results in increased activity of TP53 protein]; Cadmium inhibits the reaction [Dactinomycin results in increased expression of and results in increased activity of TP53 protein]; Dactinomycin promotes the reaction [MRPL41 protein results in increased stability of and affects the localization of TP53 protein]; Dactinomycin results in increased expression of and affects the localization of TP53 protein; Dactinomycin results in increased expression of and results in increased activity of TP53 protein; Morphine inhibits the reaction [Dactinomycin results in increased expression of TP53 protein modified form]; Naloxone inhibits the reaction [Morphine inhibits the reaction [Dactinomycin results in increased expression of TP53 protein modified form]] Dactinomycin results in increased expression of TP53 protein; Dactinomycin results in increased expression of TP53 protein modified form Dactinomycin results in increased activity of TP53 protein Actinomycin D inhibits the reaction [Sunitinib increases expression of TP53 mRNA and protein in breast epithelium] |
CTD RGD |
PMID:10531375 PMID:12807743 PMID:12869419 PMID:12927789 PMID:16024796 PMID:17581298 PMID:20655369 PMID:23968587 PMID:28870911 More...
|
RGD:150537096 |
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp53i11 |
tumor protein p53 inducible protein 11 |
multiple interactions decreases expression |
ISO |
Dactinomycin inhibits the reaction [arsenic trioxide results in increased expression of TP53I11 mRNA] Dactinomycin results in decreased expression of TP53I11 mRNA |
CTD |
PMID:19333544 |
|
NCBI chr 3:79,144,824...79,160,056
Ensembl chr 3:79,144,895...79,160,050
|
|
G |
Trpv6 |
transient receptor potential cation channel, subfamily V, member 6 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [1,25-dihydroxyvitamin D results in increased expression of TRPV6 mRNA] |
CTD |
PMID:16362534 |
|
NCBI chr 4:70,507,347...70,523,013
Ensembl chr 4:70,507,348...70,523,017
|
|
G |
Tuba4a |
tubulin, alpha 4A |
increases expression |
ISO |
Dactinomycin results in increased expression of TUBA4A mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 9:76,709,617...76,714,327
Ensembl chr 9:76,709,614...76,713,918
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Acrolein results in increased expression of TXNRD1 mRNA]; Dactinomycin inhibits the reaction [sulforaphane results in increased expression of TXNRD1 mRNA] |
CTD |
PMID:12663510 PMID:15652504 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Tymp |
thymidine phosphorylase |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [IFNA1 protein results in increased expression of TYMP mRNA]; Dactinomycin inhibits the reaction [IFNB1 protein results in increased expression of TYMP mRNA]; Dactinomycin inhibits the reaction [IFNG protein results in increased expression of TYMP mRNA]; Dactinomycin promotes the reaction [salinomycin results in increased expression of TYMP mRNA]; tanespimycin inhibits the reaction [Dactinomycin promotes the reaction [salinomycin results in increased expression of TYMP mRNA]] |
CTD |
PMID:15937643 PMID:30796972 |
|
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
|
|
G |
Tyr |
tyrosinase |
multiple interactions |
ISO EXP |
Dactinomycin inhibits the reaction [Quercetin results in increased activity of TYR protein] Dactinomycin inhibits the reaction [Phenylephrine results in increased activity of TYR protein] |
CTD |
PMID:14717847 PMID:15278367 |
|
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
|
|
G |
Ube2l3 |
ubiquitin-conjugating enzyme E2L 3 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [beta-Naphthoflavone results in increased expression of UBE2L3 mRNA]; Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of UBE2L3 mRNA] |
CTD |
PMID:26318284 |
|
NCBI chr11:83,797,722...83,838,862
Ensembl chr11:83,797,722...83,838,862
|
|
G |
Uchl1 |
ubiquitin C-terminal hydrolase L1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Mevinphos results in increased expression of UCHL1 protein] |
CTD |
PMID:15545831 |
|
NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Lipopolysaccharides results in increased expression of VCAM1 protein] Dactinomycin inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA] |
CTD |
PMID:10100995 PMID:12892526 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO EXP |
Dactinomycin inhibits the reaction [Oxaliplatin results in increased expression of VEGFA mRNA]; Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of VEGFA mRNA]; Dactinomycin inhibits the reaction [Tretinoin results in increased expression of VEGFA mRNA] Dactinomycin inhibits the reaction [Cobalt results in increased expression of VEGFA mRNA]; Dactinomycin inhibits the reaction [Estradiol results in increased expression of VEGFA mRNA alternative form]; Dactinomycin inhibits the reaction [Nickel results in increased expression of VEGFA mRNA]; Dactinomycin inhibits the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA] |
CTD |
PMID:8344219 PMID:10751333 PMID:11641398 PMID:16386082 PMID:18790786 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vim |
vimentin |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of VIM mRNA] |
CTD |
PMID:9044050 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Vmp1 |
vacuole membrane protein 1 |
multiple interactions decreases expression |
ISO |
[Dactinomycin co-treated with fludioxonil] results in decreased expression of VMP1 mRNA; Dactinomycin inhibits the reaction [Dehydroepiandrosterone results in increased expression of VMP1 mRNA]; Dactinomycin inhibits the reaction [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of VMP1 mRNA] Dactinomycin results in decreased expression of VMP1 mRNA |
CTD |
PMID:23052036 PMID:25969534 |
|
NCBI chr10:71,405,058...71,505,045
Ensembl chr10:71,405,452...71,505,007
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
decreases expression |
ISO |
Dactinomycin results in decreased expression of XIAP protein |
CTD |
PMID:12430140 |
|
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|
G |
Ythdf1 |
YTH N6-methyladenosine RNA binding protein F1 |
multiple interactions |
ISO |
YTHDF1 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]; YTHDF1 protein affects the reaction [YTHDF2 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]]; YTHDF2 protein affects the reaction [YTHDF1 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]] |
CTD |
PMID:37061066 |
|
NCBI chr 3:168,024,660...168,040,172
Ensembl chr 3:168,024,663...168,040,172
|
|
G |
Ythdf2 |
YTH N6-methyladenosine RNA binding protein F2 |
multiple interactions |
ISO |
YTHDF1 protein affects the reaction [YTHDF2 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]]; YTHDF2 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]; YTHDF2 protein affects the reaction [YTHDF1 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]] |
CTD |
PMID:37061066 |
|
NCBI chr 5:144,381,426...144,407,126
Ensembl chr 5:144,381,431...144,408,144
|
|